The purpose of this course is to provide a primer about joint ventures. First, what they are and why they formed. Next, the course will explain the antitrust implications of joint ventures, via examination of the relevant statutes, case law and agency guidelines. The course will focus on restraints imposed collectively on the venture members - - most importantly, what attributes make them illegal or not.
The course then turns to a previously published examination of a series of joint ventures: Wall Street syndicates for private underwritings in excess of $100 million. The course notes that a small oligopoly of commercial and investment banks dominates the arranging and underwriting of loans and bonds for publicly traded companies, and that each underwriting is performed by a syndicate that constitutes a joint venture of competitors. Further, that each syndicate requires the borrower to agree not to disclose the syndicate’s fee, an obligation that requires not just violation of the securities laws, but constitutes a price-related restraint of each joint venture at issue. The course concludes that the series of price-related restraints compelling price confidentiality impacts the market for the fees in question by preventing customers to compare them, or show them to competitors in fee negotiations.
A quote of interest from the underlying Article, explained in more detail during the seminar:
“One leading securities law expert has opined that ‘the failure to file these agreements suggests that it is the ‘custom and practice’ of Wall Street banks to violate the securities laws by directing customers to keep documents relating to their fees confidential”.
Also, on reviewing the article, the authors of a 2020 Article , “Collusion in Markets with Syndication,” commented that “[t]his is great. It seems like the fees are known internally through the network of banks, so they can monitor compliance with the collusive agreement, but not known externally, so it is hard for a new entrant to figure out the best way to undercut the collusive agreement.”
As the Holiday Season is upon us, the widely known “12 Days of Christmas” comes to mind ...
Session 10 of 10 - Mr. Kornblum, a highly experienced trial and litigation lawyer for over 50 years,...
This one-hour program will look at the key differences in policies available in the marketplace, dif...
Explore the transformative potential of generative AI in modern litigation. “Generative AI for...
“Maybe I drink more than I should, but it isn’t affecting my life-I’m ‘High-...
Mary Beth O'Connor will describe her personal history of 20 years of drug use and 30+ years of sobri...
Bias and discrimination continue to shape workplace dynamics, legal practice, and professional respo...
Join Steve Herman on December 8, 2025, for "Maintaining Ethical Standards: Essential Strategies for ...
"I think he drinks too much - but he's my boss!" "She's the firm's rainmaker, but something isn't r...
Addressing the sensitive subjects of incapacity, death and health care are not either seamless or pa...